Trademark Details For ABRYTOP (Serial Number 97348833)

  •  Home
  •  Print
ABRYTOP
1
3
2
0
Serial Number  United States - USPTO 97348833
Registration Number -
Mark
ABRYTOP
Filing Date Apr-06-2022
Status
Pending  
THIRD EXTENS.. (732)
THIRD EXTENSION - GRANTED
Attorney Name
TTAB
0



  • Mark Literal Elements:

005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameLaurence Rickles TEVA PHARMACEUTICALS USA, INC.
Address400 INTERPACE PARKWAY BUILDING A PARSIPPANY, NJ 07054 United States

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Apr-09-2022NEW APPLICATION ENTERED   NWAPI
Apr-11-2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Sep-20-2022ASSIGNED TO EXAMINER   DOCKD
Sep-26-2022APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Oct-12-2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Nov-01-2022PUBLISHED FOR OPPOSITION   PUBOA
Nov-01-2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Nov-21-2022EXTENSION OF TIME TO OPPOSE RECEIVED   ETOFT
Dec-15-2022TEAS PETITION TO AMEND BASIS RECEIVED   TPADI
Dec-15-2022POST PUBLICATION AMENDMENT RECEIVED   PPARI
Jan-10-2023ASSIGNED TO PETITION STAFF   APETA
Jan-11-2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED   ETOPT
Jan-13-2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED   CHPBI
Feb-28-2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Aug-16-2023SOU TEAS EXTENSION RECEIVED   EEXTI
Aug-16-2023SOU EXTENSION 1 FILED   EXT1S
Aug-16-2023SOU EXTENSION 1 GRANTED   EX1GS
Aug-18-2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Feb-27-2024SOU TEAS EXTENSION RECEIVED   EEXTI
Feb-27-2024SOU EXTENSION 2 FILED   EXT2S
Feb-27-2024SOU EXTENSION 2 GRANTED   EX2GS
Feb-28-2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Aug-19-2024SOU TEAS EXTENSION RECEIVED   EEXTI
Aug-19-2024SOU EXTENSION 3 FILED   EXT3S
Aug-19-2024SOU EXTENSION 3 GRANTED   EX3GS
Aug-19-2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE